Close
As part of Deciphera’s Global All Company Meeting in October 2025, em...
We have established a policy for reducing GHG emissions based on rece...
We have two GMP-compliant production sites, namely our Fujiyama Plant (...
To help employees feel a personal connection to global environmental i...
Reporting System We have established internal and external points o...
Our efforts to promote diversity focus on three main areas: management*, ...
We agree with the purport of the "Council on Promoting Partnership Buildi...
The total water withdrawal in FY2025 was 186.0 thousand m3, a reduction ...
We disclose financial results and other timely disclosure information...
As safety and health risk management, we are implementing potential risk ...
We strive to secure a market-competitive level of compensation, taking in...
Our Stance on Sustainable Procurement Joining the PSCI (Pharmaceutica...
As for water risks, the Environmental Management Committee and the Nature...
EHS Global Policy EHS Promotion System Building and Operating the E...
Policy for Realization of a Water Recycling Society Analysis and Eval...
Even today as we see remarkable developments in the medical field, there ...
We have established four growth strategies to realize our corporate ph...
Governance This structure is as of Jul...
Support for Disease Prevention, Early Detection and Early Treatment ...
Traveling Science Workshop "Kusuri no Himitsu Manabu" Efforts for Canc...
In 2019, to realize a sustainable society, we formulated our medium- to l...
We are moving ahead with activities to achieve our medium- to long-ter...
We recognize our responsibility, as a pharmaceutical company involved in ...
Basic Policy for Human Rights Human Rights Due Diligence Access to...
